EBV-Driven CD4+ T Cells Link Epstein-Barr Virus to MS, Opening Immunotherapy Avenues

1 min read
Source: Nature
EBV-Driven CD4+ T Cells Link Epstein-Barr Virus to MS, Opening Immunotherapy Avenues
Photo: Nature
TL;DR Summary

New research shows Epstein–Barr virus activates CD4+ T cells that attack nerve insulation in multiple sclerosis, and that anti-CD20 therapies (which reduce B cells and viral stimuli) lower CD4+ T-cell responses and EBV activity—hinting immunotherapies could slow relapses and progression.

Share this article

Reading Insights

Total Reads

1

Unique Readers

2

Time Saved

6 min

vs 7 min read

Condensed

97%

1,26540 words

Want the full story? Read the original article

Read on Nature